Integra Lifesciences Holdings Corp (NASDAQ:IART)
| 39.05 Delayed Data As of Nov 28 |  +0.38 / +0.98%Today’s Change | 33.44 Today|||52-Week Range 60.69 | -30.35% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Operating Activities | Net Income / Starting Line | 13.3M | 25.1M | 32.8M | 29.7M | |
| Depreciation | 29.1M | 27.7M | 27.1M | 26.9M | ||
| Total Other Cash Flow | 13.0M | 1.7M | 6.0M | 13.0M | ||
| Funds From Operations | 56.5M | 45.5M | 59.0M | 67.4M | ||
| Funds From/For Other Operating Expenses | -22.7M | 7.9M | 29.5M | 18.8M | ||
| Net Cash Flow - Operating Activities | 79.3M | 37.7M | 29.5M | 48.5M | ||
| Investing | Capital Expenditures | -16.7M | -25.7M | -16.1M | -17.7M | |
| Fixed Asset Disposal | 93.0K | 124.0K | 35.0K | 0.00 | ||
| Other Investing - Sources | 233.0K | 231.0K | 245.0K | 250.0K | ||
| Net Cash Flow Investing | -16.3M | -25.3M | -15.8M | -17.4M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | -167.0K | 125.6M | 67.2M | 34.0M | ||
| Long Term Debt Reduction | -45.0M | -200.0M | -57.4M | -47.6M | ||
| Net Proceeds Stock Sale | 5.5M | 153.0K | 1.8M | 463.0K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 175.0K | 4.8M | 6.2M | 55.0K | ||
| Net Cash Flow - Financing | -39.8M | -79.0M | 5.4M | -13.2M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -849.0K | -456.0K | -884.0K | 1.1M | |
| Net Change In Cash | 23.1M | -66.7M | 19.1M | 17.9M | ||
